Pharmacologic Antagonization of Cannabinoid Receptor 1 Improves Cholestasis in Abcb4<sup>-/-</sup> Mice.

Cell Mol Gastroenterol Hepatol · 2022 · PMC8873597 · PMID 34954190

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The cholestasis-dependent increase of hepatic hydroxyproline content in Abcb4 -/- mice appeared slightly reduced by ACEA and rimonabant treatment, but did not reach statistical significance ( Figure 5 E ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.